Quarterly Statistical Report st Quarter

Slides:

Advertisements

Similar presentations

Oklahoma Aggregate Data 1st Quarter 2013 January 1 – March 31, 2013 EVERY WEEK COUNTS.

Advertisements

Are we ready to implant LVAD’s in the less sick? Ileana L. Piña, MD, MPH Professor of Medicine and Epi/Pop Health Albert Einstein College of Medicine Associate.

VALUE BASED CARE: The Role of INTERMACS INTERMACS 8 TH Annual Meeting James B, Young, M.D. Study Chair – INTERMACS May 5 th, 2014.

Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic, OH HeartMate II Pump Thrombosis.

Hemolysis in Patients Supported with Durable, Long-Term Left Ventricular Assist Device Therapy Jason N. Katz, MD,MHS; Brian C. Jensen, MD; Patricia P.

Sixth Annual Meeting March 12, :00am to 4:00pm Crowne Plaza National Airport Arlington, VA INTERMACS Annual Meeting March 2012.

Predicting Major Outcomes after MCSD Implant 1 Risk Factors for Death, Transplant, and Recovery James Kirklin, MD David Naftel, PhD.

Coordinator Training Session: March 11, 2012 Major Changes in Data EntryMyers 1 What is the same? What is reduced/removed? What is added/expanded? INTERMACS.

Sixth Annual Meeting Coordinator Training Session March 11, :00pm to 9:00pm Arlington, VA 1 INTERMACS Coordinator Training March 2012.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

7.35PHTS Business DCC Update/QID. Naftel Database CommitteeR. Gajarski (W. Mahle) Foundation UpdateA. Dipchand Financial RoadmapW. Mahle 8:15 Hard to Forget:

Predicting Major Outcomes after MCSD Implant 1 Risk Factors for Death, Transplant, and Recovery James Kirklin, MD David Naftel, PhD.

Interagency Registry for Mechanically Assisted Circulatory Support Marissa A. Miller, DVM, MPH National Heart, Lung, & Blood Institute.

2011 ACRIN Annual Meeting The ACRIN Accrual Project at University of Washington Constance Lehman, MD. PhD David Mankoff, MD. PhD Tiffany Wong, MS.

Our Commitment to Patients and Transplant Recipients Dr. Butchi Paidipaity, MD.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

INTERMACS: June 2006 – December 2012: CMS Report Adults: n=7849 All primary implants as of 12/31/2012 n= 7928 Pediatric patients: n=79 (patients < 19 yrs.

7.35PHTS Business DCC Update/QID. Naftel Database CommitteeR. Gajarski (W. Mahle) Foundation UpdateA. Dipchand Financial RoadmapW. Mahle 8:15 Hard to Forget:

Session III: Linking Intermacs to the World: The Power of Collaboration Intermacs and the ISHLT Registry for Mechanically Assisted Circulatory Support.

1 Data Quality Report Quality Assurance Report Live Data Download Site Datasets (SAS) Research Datasets Customized Cohort Reports Outcome Analytics Patient.

1 Intermacs 10 th Annual Meeting and Scientific Sessions Intermacs: Products for the Sites Friday, March 11, 2016: 7:00-8:30pm Omni Hotel, Grand Ballroom.

本课内容导读：一、传统戏曲的表现内容二、传统戏曲的特点三、现代戏曲出现了哪些新变化一、传统戏曲的表现内容传统戏曲的表现内容大体来说可以分为三类，通过下面三个戏曲片段的欣赏，我们共同总结一下是哪三类。

Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Results of the Destination Therapy Post-Food and.

Session I: Web Based Reporting: What You Can Get From the Database Data Quality Report Quality Assurance Report I. Accessing Your Data Examining/Validating.

Annual Spring Meeting April 5, 2017

Department of Legal Medicine Armed Forces Institute of Pathology

Annual Fall Meeting November 13, 2016

Patterns and Predictors of Physical Functional Disability at 5 to 10 Years After Heart Transplantation Kathleen L. Grady, PhD, RN, David C. Naftel, PhD,

10th Annual Meeting: Friday, March 11th – Products for the Sites

Annual Fall Meeting November 13, 2016

James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L

INTERMACS 10th Annual Meeting March , 2016 Quality of Life

From the Dry Run and National Implementation of the

Annual Fall Meeting November 13, 2016

Jennifer A. Cowger, MD, Matthew A

Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study Waldemar.

Annual Spring Meeting April 26, 2016

Intermacs and the Scientific Registry of Transplant Recipients (SRTR)

Adverse Events in Children Implanted With Ventricular Assist Devices in the US: Data From the Pediatric Interagency Registry for Mechanical Circulatory.

Agenda 7:30pm Welcome M. Everitt/R. Chinnock/J. Alejos 7:40pm

Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients James K. Kirklin, MD, David C. Naftel,

Risk scores for predicting mortality after surgical ventricular reconstruction for ischemic cardiomyopathy: Results of a Japanese multicenter study Satoru.

Pediatric Registry for Mechanically Assisted Circulatory Support

Interagency Registry for Mechanically Assisted Circulatory Support Web-Based Reporting What can you get from the Database? Friday March 3, 2017.

Agenda 7:30pm Welcome M. Everitt/R. Chinnock/J. Alejos 7:40pm

Studies set up as Summary Accrual Only OnCore Non-Cancer Studies (MZ)

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy Francis D Pagani, MD, PhD, Keith D Aaronson, MD, David B Dyke,

Agenda 7:30pm Welcome M. Everitt/R. Chinnock/J. Alejos 7:40pm

Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation? James K. Kirklin, MD, David C. Naftel,

Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry Jens Garbade, MD, PhD, Finn Gustafsson,

Quarterly Statistical Report th Quarter

Discussions in Cardiothoracic Treatment and Care: Mechanical Circulatory Support Left Ventricular Assist Device Therapy for Patients With Advanced Heart.

Interagency Registry for Mechanically Assisted Circulatory Support

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L.

William L. Holman, MD, James K. Kirklin, MD, David C

What are patients doing with their mosaic embryos

Linking Intermacs to the World:

Initial Clinical Experience With the HeartWare Left Ventricular Assist System: A Single- Center Report Angelo Maria Dell'Aquila, MD, Stefan Rudolf Bertram.

Francisco A. Arabía, MD, MBA, Carmelo A

Jacqueline Baras Shreibati et al. JCHF 2017;j.jchf

Pediatric Registry for Mechanically Assisted Circulatory Support

Interagency Registry for Mechanically Assisted Circulatory Support

Development of a System to Measure and Improve Outcomes in Congenital Heart Disease: Heart Institute Safety, Quality, and Value Program Katherine Clarke-Myers,

A prospective algorithm for the management of air leaks after pulmonary resection Robert J Cerfolio, MD, Ramu P Tummala, BS, William L Holman, MD, George.

Interagency Registry for Mechanically Assisted Circulatory Support

Kathleen E. Simpson, MD, Elizabeth Pruitt, MSPH, James K

Quarterly Statistical Report rd Quarter

Presentation transcript:

INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2013 1st Quarter Implant dates: June 23, 2006 – March 31, 2013 Prepared by: The Data Collection and Analysis Center University of Alabama at Birmingham For questions or comments contact: James K. Kirklin, MD at jkirklin@uab.edu David C. Naftel, Ph.D at dnaftel@uab.edu Susan L. Myers at slm@uab.edu Mary Lynne Clark at mlclark@uab.edu Stephen Craig Collum at ccollum@uab.edu Kathryn Hollifield at kathryn@uab.edu Ryan S. Cantor at rcantor@uab.edu

INTERMACS Between June 23, 2006 and March 31, 2013, 153 hospitals participated in INTERMACS and, of these, 141 hospitals actively contributed information on a total of 8609 patients. Cumulative patient accrual and the number of participating hospitals over this time period are displayed above.

INTERMACS

INTERMACS

INTERMACS

INTERMACS

INTERMACS

INTERMACS

INTERMACS

INTERMACS

INTERMACS

INTERMACS

INTERMACS